About Us

Our key values for patients, leadership, innovation, continuous improvement and teamwork brings us together and drive commitment to deliver meaningful value.

Nucrogene is committed to constantly elevating and refining the value it delivers to its patients, customers and investors.

Nucrogene is fastest growing generic pharmaceutical company and engaged to develop, manufacture, commercialize and market specialty generic prescription medicines as well as over the counter medicines. Nucrogene develop products with focus on wide range of therapeutic areas including, cardiovascular, proton pump inhibitors, anti-infective and anti-inflammatory diseases and other medical conditions in the United States, Latin America, Europe and international market. Dosage forms include immediate release (IR), extended release(ER), Delayed release(DR) tablets, capsules, liquids, suspensions, and transdermal. Nucrogene’s goal is to come up with more generic medicines to improve quality of life for patients with high quality, cost effective medicines.